 
            IndraLab
Statements
USP1 activates DNA repair. 10 / 10
                        
    
      
      
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
      
    
      
      
        |
        
      
      
        
          
          1
          
        
      
        
      
        
          
          9
          
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
      
    
  
                      
                    
                                      reach
                                
                                  
                                
                                
          
          
                                  "Because CHK1 is a cell cycle regulated and DNA damage checkpoint protein, we asked whether (a) the downregulation of CHK1 in USP1 depleted cells is an experimental artefact resulting from modifications of the cell cycle and/or altered DNA repair capabilities caused by USP1 depletion and (b) USP1 depletion modifies the G2 checkpoint in response to DNA damage."
          
                              
          
                               
                            
                                      reach
                                
                                  
                                
                                
          
          
                                  "These results suggest that inhibition of the expression of USP1 has great potential to inhibit DNA repair, leading to increased DNA damage originated from DNA alkylating agents such as cisplatin, and ultimately enhancing the anti-tumor effect.Subsequently, we verified that a selective USP1i of C527 in combination of cisplatin showed obvious synergistic anti-tumor effect, which holds great promise for further combination therapy."